Charles Schwab Investment Management Inc Spring Works Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 602,227 shares of SWTX stock, worth $21.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

602,227

Previous 528,614 13.93%

Holding current value

$21.4 Million

Previous $19.9 Million 3.1%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$32.04 - $42.76 $2.36 Million - $3.15 Million	73,613 Added 13.93%	602,227 $19.3 Million
Q2 2024 Aug 12, 2024	BUY	$36.06 - $47.62 $383,714 - $506,724	10,641 Added 2.05%	528,614 $19.9 Million
Q1 2024 May 08, 2024	BUY	$36.5 - $52.5 $617,069 - $887,565	16,906 Added 3.37%	517,973 $25.5 Million
Q4 2023 Feb 06, 2024	BUY	$18.94 - $37.24 $1.46 Million - $2.88 Million	77,303 Added 18.24%	501,067 $18.3 Million
Q3 2023 Nov 08, 2023	BUY	$23.12 - $31.38 $1.37 Million - $1.86 Million	59,138 Added 16.22%	423,764 $9.8 Million
Q2 2023 Aug 09, 2023	BUY	$23.15 - $32.71 $1.23 Million - $1.74 Million	53,247 Added 17.1%	364,626 $9.56 Million
Q1 2023 May 11, 2023	BUY	$24.97 - $34.05 $10,087 - $13,756	404 Added 0.13%	311,379 $8.01 Million
Q4 2022 Feb 13, 2023	BUY	$21.73 - $28.72 $1.6 Million - $2.11 Million	73,432 Added 30.91%	310,975 $8.09 Million
Q3 2022 Nov 14, 2022	BUY	$24.1 - $39.66 $760,596 - $1.25 Million	31,560 Added 15.32%	237,543 $6.78 Million
Q2 2022 Aug 15, 2022	BUY	$18.36 - $60.07 $153,471 - $502,125	8,359 Added 4.23%	205,983 $5.07 Million
Q1 2022 May 13, 2022	BUY	$48.97 - $65.46 $311,694 - $416,652	6,365 Added 3.33%	197,624 $11.2 Million
Q4 2021 Feb 11, 2022	BUY	$53.3 - $75.84 $161,445 - $229,719	3,029 Added 1.61%	191,259 $11.9 Million
Q3 2021 Nov 16, 2021	SELL	$62.66 - $88.26 $307,911 - $433,709	-4,914 Reduced 2.54%	188,230 $11.9 Million
Q2 2021 Aug 16, 2021	BUY	$67.45 - $85.63 $900,997 - $1.14 Million	13,358 Added 7.43%	193,144 $15.9 Million
Q1 2021 May 17, 2021	BUY	$65.1 - $93.59 $385,391 - $554,052	5,920 Added 3.4%	179,786 $13.2 Million
Q4 2020 Feb 16, 2021	BUY	$48.36 - $77.92 $1.56 Million - $2.52 Million	32,358 Added 22.87%	173,866 $12.6 Million
Q3 2020 Nov 13, 2020	BUY	$36.14 - $51.99 $1.96 Million - $2.82 Million	54,187 Added 62.05%	141,508 $6.75 Million
Q2 2020 Aug 14, 2020	BUY	$22.98 - $48.57 $622,229 - $1.32 Million	27,077 Added 44.95%	87,321 $3.67 Million
Q1 2020 May 15, 2020	BUY	$20.44 - $41.21 $26,837 - $54,108	1,313 Added 2.23%	60,244 $1.63 Million
Q4 2019 Feb 07, 2020	BUY	$17.74 - $39.52 $1.05 Million - $2.33 Million	58,931 New	58,931 $2.27 Million

Others Institutions Holding SWTX

# of Institutions

237

Shares Held

68.9M

Call Options Held

144K

Put Options Held

257K

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.22B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Spring Works Therapeutics, Inc. Transaction History